Credit Suisse Downgrades Clover Biopharmaceuticals Ltd (2197:HK) to Neutral
Tweet
Share
E-mailGet Alerts 2197:HK Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 32 | New: 9
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 32 | New: 9
Join SI Premium – FREE
Credit Suisse analyst Yang Huang downgraded Clover Biopharmaceuticals Ltd (2197:HK) from Outperform to Neutral with a price target of HK$4.80 (from HK$3.40).
You May Also Be Interested In
- Nihon Kohden Corp (6849:JP) PT Lowered to JPY5,200 at Nomura/Instinet
- BDO Unibank, Inc (BDO:PM) (BDOUY) PT Raised to PHP162.90 at CLSA
- JPMorgan Upgrades Mapletree Logistics Trust (MAPL:SP) (MAPGF) to Overweight
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
